Therapy

Antiplatelet and Anticoagulation Therapy by Stan Heptinstall B.Sc., Ph.D. (auth.), Albert Ferro, David

By Stan Heptinstall B.Sc., Ph.D. (auth.), Albert Ferro, David A. Garcia (eds.)

This identify could be provided as hugely useful info pn pharmaceutical antiplatelet and anticoagulation treatment, written in a quick-access, no-nonsense structure. The emphasis may be on a just-the-facts medical technique, heavy on tabular fabric, gentle on dense prose. The involvement of the ISCP will make sure that the very best quality participants can be concerned and identify a constant method of each one subject within the sequence. every one quantity is designed to be among a hundred and twenty and 250 pages containing useful illustrations and designed to enhance comprehend and functional utilization of cardiovascular medicinal drugs in particular scientific areas.

Show description

Read Online or Download Antiplatelet and Anticoagulation Therapy PDF

Best therapy books

Comprehensive Handbook of Cognitive Therapy

This guide covers all of the many points of cognitive remedy either in its sensible software in a scientific atmosphere and in its theoretical facets. because the first functions of cognitive remedy over 20 years in the past, the sector has increased enormously.
This e-book offers a welcome and readable evaluation of those advances.

Handbook of Psychotherapy Integration

This quantity, initially released in 1992 by way of uncomplicated Books, presents for the 1st time a accomplished cutting-edge description of healing integration and its medical practices by way of the prime proponents of the circulation. After proposing the techniques, background, learn, and trust constitution of psychotherapy integration, the e-book considers exemplars of theoretical integration, technical eclecticism, and customary components.

Extra info for Antiplatelet and Anticoagulation Therapy

Example text

Agents that act as antagonists at the EP3 receptor on platelets provide a potential new approach to antithrombotic therapy. Conflicts of Interest Stan Heptinstall on behalf of the University of Nottingham has received research grants for laboratory investigations on the P2Y12 antagonists clopidogrel, prasugrel, ticagrelor and cangrelor and the EP3 antagonist DG-041. He is also a shareholder and director of Platelet Solutions Ltd, a spinout company of the University of Nottingham that engages in platelet function testing.

Unlike clopidogrel and prasugrel the inhibition is reversible rather than irreversible, which means that the drug can come off the receptor when treatment is curtailed and platelet function can be restored. However, in actuality, this reversal of inhibition is quite slow (see below). Like clopidogrel and prasugrel, ticagrelor does have an active metabolite but this is present in lower quantities than the parent drug and it appears to act in an identical manner to the parent drug [45]. There have been a number of studies in which the pharmacological effects of ticagrelor have been compared with those of clopidogrel.

Circulation. 2011;123:1891–9. 78. Firbas C, Siller-Matula JM, Jilma B. Targeting von willebrand factor and platelet glycoprotein Ib receptor. Expert Rev Cardiovasc Ther. 2010;8:1689–701. 79. Heptinstall S, Espinosa DI, Manolopoulos P, Glenn JR, White AE, Johnson A, Dovlatova N, Fox SC, May JA, Hermann D, Magnusson O, Stefansson K, Hartman D, Gurney M. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 2008;19:605–13.

Download PDF sample

Rated 5.00 of 5 – based on 6 votes